A single-centre, randomized, double-blind, crossover, single-dose clinical trial to compare bilastine, desloratadine, rupatadine and placebo in the suppression of wheal and flare induced by intradermal histamine in healthy volunteers.
Phase of Trial: Phase IV
Latest Information Update: 01 Jan 2017
At a glance
- Drugs Bilastine (Primary) ; Desloratadine (Primary) ; Rupatadine (Primary)
- Indications Allergic conjunctivitis; Perennial allergic rhinitis; Seasonal allergic rhinitis; Urticaria
- Focus Therapeutic Use
- Sponsors FAES Farma
- 10 Oct 2015 Status changed from recruiting to completed, according to European Clinical Trials Database record.
- 26 Aug 2015 New trial record